Fed. Circ. Denies Rehearing In Merck Patent Loss Case
The Federal Circuit won't revisit its May ruling that a Merck KGaA patent claim involving oral contraceptives Safyral and Beyaz is invalid because Merck had offered to sell its invention before...To view the full article, register now.
Already a subscriber? Click here to view full article